Sign in Pull a receipt

OVID

Ovid Therapeutics Inc.

Healthcare · Biotechnology

$237.61 sample

+2.26 (+0.96%) 1D

Market cap

$1.35T

Price as of

2026-10-29

Latest filing

8-K

Alerts

8

Price$237.61 +4.80% 3M daily closessample

237.61220.88

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider sell: General Counsel
Oct 20INSInsider buy: 10% owner
Oct 12INSInsider buy: Chief Executive Officer
Oct 05INSInsider sell: EVP, Operations
Sep 24INSInsider sell: Chief Financial Officer
Sep 16INSInsider sell: Director
Sep 08INSInsider sell: General Counsel
Sep 02INSInsider buy: General Counsel

Sign up to see the real OVID record →

Company facts

SEC EDGAR registration

Name: Ovid Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +20sample, -100 to +100
Reporting currency: USD

Who is positioning in OVID

sample

Insiders: 7 insider transactions over 90 days, net selling, $745.3M
Congress: 3 members traded over 90 days
Institutions · 13F: 44 funds hold $10.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$86.3B +17.1% y/y

Q4 2024Q3 2026

Inventory$49.0B +15.3% y/y

Q4 2024Q3 2026

Accounts receivable$36.0B +9.4% y/y

Q4 2024Q3 2026

Total debt$100.7B +8.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $254.9B -3.5% 3M
Sample peer B: $966.0B -4.6% 3M
Sample peer C: $543.4B +8.2% 3M
Sample peer D: $557.3B +2.0% 3M
Sample peer E: $186.0B +4.1% 3M